A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT06276933 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06276933
- Sponsor
- Tongji University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-22
- Primary completion
- 2025-11-22
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.